|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| Peripheral Vascular Diseases | |||||
| Atherosclerosis | |||||
| Cerebrovascular Disorders | |||||
| Myocardial Infarction | |||||
| Heart Diseases | |||||
| Hyperhomocysteinemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Infarction | |||||
| Vascular Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Amino Acid Metabolism, Inborn Errors | |||||
| Arterial Occlusive Diseases | |||||
| Arteriosclerosis | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Ischemia | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Myocardial Ischemia | |||||
| Necrosis | |||||
| Nervous System Diseases | |||||
| Pathologic Processes | |||||
| 4 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||